Forza X1, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000173112224000498 Filed on March 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.953M	$12.80M	$12.80M
YoY Change	-6.84%	0.28%	0.28%
Cash & Equivalents	$9.953M	$9.822M	$9.822M
Short-Term Investments	$0.00	$2.982M	$2.982M
Other Short-Term Assets	$129.5K	$73.51K	$73.51K
YoY Change	-73.9%	-85.86%	-85.86%
Inventory	$403.6K	$493.5K	$493.5K
Prepaid Expenses
Receivables		$0.00
Other Receivables
Total Short-Term Assets	$10.49M	$13.37M	$13.37M
YoY Change	-6.56%	0.63%	0.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.984M	$3.469M	$3.544M
YoY Change	387.85%	353.22%	282.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.520K	$7.520K	$7.520K
YoY Change	0.0%	0.0%	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$5.045M	$3.552M	$3.552M
YoY Change	331.22%	279.86%	279.85%
TOTAL ASSETS
Total Short-Term Assets	$10.49M	$13.37M	$13.37M
Total Long-Term Assets	$5.045M	$3.552M	$3.552M
Total Assets	$15.53M	$16.92M	$16.92M
YoY Change	25.33%	18.98%	18.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$34.27K	$86.82K	$86.82K
YoY Change	-30.84%	-12.33%	-12.33%
Accrued Expenses	$72.78K	$462.4K	$530.9K
YoY Change	-5.69%	398.43%	196.58%
Deferred Revenue	$5.700K	$5.700K
YoY Change	-1.72%	7.55%
Short-Term Debt	$122.3K	$201.9K	$201.9K
YoY Change		18.84%	18.84%
Long-Term Debt Due	$25.23K	$17.31K	$17.31K
YoY Change	49.91%
Total Short-Term Liabilities	$306.2K	$842.6K	$842.6K
YoY Change	29.13%	85.92%	85.92%
LONG-TERM LIABILITIES
Long-Term Debt	$78.46K	$58.72K	$58.72K
YoY Change	7.86%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$78.46K	$58.72K	$58.72K
YoY Change	-33.88%	-14.31%	-14.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$306.2K	$842.6K	$842.6K
Total Long-Term Liabilities	$78.46K	$58.72K	$58.72K
Total Liabilities	$384.7K	$901.3K	$901.3K
YoY Change	8.12%	72.76%	72.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.19M	-$10.02M
YoY Change	83.64%	145.15%
Common Stock	$15.78K	$15.78K
YoY Change	51.04%	51.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$21.38K	$21.38K
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.15M	$16.02M	$16.02M
YoY Change
Total Liabilities & Shareholders Equity	$15.53M	$16.92M	$16.92M
YoY Change	25.33%	18.98%	18.98%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001901305
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022	FRZA	Net Sales Of Related Party NetSalesOfRelatedParty		usd
CY2022	FRZA	Cost Of Sales Related Party CostOfSalesRelatedParty		usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022	FRZA	Change In Inventory Reserve ChangeInInventoryReserve		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent		usd
CY2022	FRZA	Finance Lease FinanceLease		usd
CY2022	FRZA	Right Of Use Asset Finance Leases RightOfUseAssetFinanceLeases		usd
CY2023	FRZA	Right Of Use Asset RightOfUseAsset		usd
CY2023Q4	FRZA	Marketable Securities Gross Unrealized Losses MarketableSecuritiesGrossUnrealizedLosses		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
CY2022	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited		usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits		usd
CY2022	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	City Area Code CityAreaCode	772
CY2023	dei	Local Phone Number LocalPhoneNumber	429-2525
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023	dei	Trading Symbol TradingSymbol	FRZA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	23200000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15754774	shares
CY2023	dei	Auditor Firm AuditorFirmId	606
CY2023	dei	Auditor Name AuditorName	GRASSI & CO., CPAs, P.C.
CY2023	dei	Auditor Location AuditorLocation	Jericho, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2981720	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	493460	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73508	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	519735	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	13370219	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13286934	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75147	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	162069	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3468961	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	765406	usd
CY2023Q4	us-gaap	Assets Assets	16921844	usd
CY2022Q4	us-gaap	Assets Assets	14221926	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	86820	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	99028	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462381	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92767	usd
CY2023Q4	FRZA	Due To Affiliated Companies DueToAffiliatedCompanies	201848	usd
CY2022Q4	FRZA	Due To Affiliated Companies DueToAffiliatedCompanies	169851	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17313	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68532	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86245	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	507794	usd
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	43294	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	50878	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	103941	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-31582	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	660320	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	23178	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-5933113	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-3630081	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5933113	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3630081	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13365613	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13365613	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8332735	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8332735	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1542449	usd
CY2022	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	500000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14829489	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	458346	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-3630081	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6929552	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	21379	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1345270	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-5933113	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16020533	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5933113	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3630081	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	185900	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59965	usd
CY2023	FRZA	Change In Fair Value Of Marketable Securities Available For Sale ChangeInFairValueOfMarketableSecuritiesAvailableForSale	50878	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1345270	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	458346	usd
CY2023	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	-86922	usd
CY2022	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	162069	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-31582	usd
CY2023	FRZA	Change In Inventory Reserve ChangeInInventoryReserve	351158	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	844618	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-446227	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	431258	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-7517	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12208	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	85695	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	369614	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	57639	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	400	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5300	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-94954	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	154777	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4150280	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3377621	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2826901	usd
CY2023	FRZA	Realized Gain On Sale Of Marketable Securities RealizedGainOnSaleOfMarketableSecurities	103941	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2797050	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	606726	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5727892	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-606726	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6996015	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15231350	usd
CY2023	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	66463	usd
CY2022	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	296361	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	21379	usd
CY2022	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	500000	usd
CY2023	FRZA	Finance Lease FinanceLease	7666	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	510556	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1099468	usd
CY2023	FRZA	Advances From Affiliates AdvancesFromAffiliates	542553	usd
CY2022	FRZA	Advances From Affiliates AdvancesFromAffiliates	612740	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6932504	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14948261	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2945668	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	10963914	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12767199	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1803285	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9821531	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12767199	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3694	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	3286	usd
CY2023	FRZA	Right Of Use Asset Finance Leases RightOfUseAssetFinanceLeases	92405	usd
CY2022	FRZA	Right Of Use Asset RightOfUseAsset	183106	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zElKut6aRCyf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_868_zahpEMX5MUJ5">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP required management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zAEcK8CNTcA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86D_z8Vkmz8kqSzg">Concentrations of Credit and Business Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of trade receivables. Credit risk on trade receivables is mitigated as a result of the Company’s use of trade letters of credit and the geographically diversified nature of the Company’s customer base. The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_905_ecustom--FdicInsuredLimit_iI_c20231231_zVD34NQYP34l" title="FDIC insured limit">250,000</span> are at risk. As of December 31, 2023 and 2022, the Company had $<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20231231_z4GmA85Jbv47" title="FDIC excess amount">12,539,519</span> and $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zKaq4XHmRhn7" title="FDIC excess amount">12,446,216</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4	FRZA	Fdic Insured Limit FdicInsuredLimit	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	12539519	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	12446216	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2023Q4	us-gaap	Other Inventory OtherInventory	351158	usd
CY2022Q4	us-gaap	Other Inventory OtherInventory	0	usd
CY2023	us-gaap	Lease Cost LeaseCost	83360	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1270104	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	957220	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	99034	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	11177	usd
CY2023Q1	FRZA	Net Asset Value NetAssetValue	48826	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q4	FRZA	Marketable Securities Amortized Cost MarketableSecuritiesAmortizedCost	2930842	usd
CY2023Q4	FRZA	Marketable Securities Gross Unrealized Gains MarketableSecuritiesGrossUnrealizedGains	50878	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	2981720	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	2981720	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3703372	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	813917	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	234411	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	48511	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3468961	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	765406	usd
CY2023	us-gaap	Depreciation Depreciation	185900	usd
CY2022	us-gaap	Depreciation Depreciation	59965	usd
CY2022Q4	FRZA	Treasury Stock Acquired Average Cost Precentage TreasuryStockAcquiredAverageCostPrecentage	0.0033	pure
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	7715	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.03	pure
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75147	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	162069	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68532	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86245	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68532	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68532	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	154777	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	69680	usd
CY2023Q4	FRZA	Lessee Operating Leases Liability Payments Due LesseeOperatingLeasesLiabilityPaymentsDue	69680	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	133	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68532	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P0Y8M15D
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	83360	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5700	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5300	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	842594	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	453191	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	58717	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68532	usd
CY2023Q4	us-gaap	Liabilities Liabilities	901311	usd
CY2022Q4	us-gaap	Liabilities Liabilities	521723	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15784000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10450000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15754774	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10450000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10450	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	29226	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	21379	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26046873	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17777385	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10020745	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4087632	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16020533	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16921844	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14221926	usd
CY2023	FRZA	Net Sales Of Related Party NetSalesOfRelatedParty	37118	usd
CY2023	FRZA	Cost Of Sales Related Party CostOfSalesRelatedParty	33744	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	123893	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	232744	usd
CY2023	us-gaap	Gross Profit GrossProfit	-120519	usd
CY2022	us-gaap	Gross Profit GrossProfit	-232744	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1540903	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	957220	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	353996	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	159304	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	185900	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	59965	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6472914	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	3420515	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-6593433	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3653259	usd
CY2023	us-gaap	Interest Expense InterestExpense	3694	usd
CY2022	us-gaap	Interest Expense InterestExpense	3286	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	1401	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	14752	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.030	pure
CY2023Q1	FRZA	Net Asset Value NetAssetValue	43579	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17313	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	58717	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	20950	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	20950	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	20950	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	20945	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	875	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	84675	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	8645	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	76030	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	59177	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	56581	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	403204	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36186	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462381	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92767	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	390825	usd
CY2023	us-gaap	Revenues Revenues	37118	usd
CY2023	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	33744	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	510556	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1099468	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	542553	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	612740	usd
CY2022Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments	2500	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	20000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	10000	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	172500	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.25
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	306705	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.88
CY2023	FRZA	Warrant Activity WarrantActivity	0	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	29226	shares
CY2023Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	21.379
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1345270	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	458346	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.08	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.13	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.10	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.13	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0298	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0472	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0298	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0362	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1441500	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.41
CY2022	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P10Y
CY2022	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted	4009913	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1441500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.41
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P0Y18D
CY2022Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	518000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.70
CY2023	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P9Y9M3D
CY2023	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted	287835	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	69583	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.24
CY2023	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P9Y7M13D
CY2023	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited	-40248	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1889917	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.75
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y4M9D
CY2023Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4257500	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	611250	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.79
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M14D
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	875000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	532000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	875000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	532000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	443000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1507000	usd
CY2023	FRZA	Effective Income Tax Rate Reconciliation At Federal Statutory Income Taxes Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxesRate	0.21	pure
CY2023	FRZA	Effective Income Tax Rate Reconciliation Taxes Contingencies State And Local EffectiveIncomeTaxRateReconciliationTaxesContingenciesStateAndLocal	0.02	pure
CY2023	FRZA	Effective Income Tax Rate Reconciliation At Federal Statutory Income Taxes Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxesRate	0.210	pure
CY2022	FRZA	Effective Income Tax Rate Reconciliation At Federal Statutory Income Taxes Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxesRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies State And Local EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal	0.020	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies State And Local EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal	0.020	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.230	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.230	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5933113	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3630081	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13365613	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8332735	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13365613	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8332735	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-000498-index-headers.html	Edgar Link	pending
0001731122-24-000498-index.html	Edgar Link	pending
0001731122-24-000498.txt	Edgar Link	pending
0001731122-24-000498-xbrl.zip	Edgar Link	pending
e5513_10k.htm	Edgar Link	pending
e5513_ex23-1.htm	Edgar Link	pending
e5513_ex31-1.htm	Edgar Link	pending
e5513_ex31-2.htm	Edgar Link	pending
e5513_ex32-1.htm	Edgar Link	pending
e5513_ex32-2.htm	Edgar Link	pending
e5513_ex4-3.htm	Edgar Link	pending
e5513_ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frza-20231231.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
frza-20231231_def.xml	Edgar Link	unprocessable
frza-20231231_lab.xml	Edgar Link	unprocessable
frza-20231231_pre.xml	Edgar Link	unprocessable
e5513_10k_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
frza-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Forza X1, Inc.

2024 Q1 Form 10-K Financial Statement

#000173112224000498 Filed on March 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission